 BRIDGEWATER, N.J., May 19, 2021 PRNewswire -- Insmed Incorporated Nasdaq:INSM, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported data from a total of nine posters and oral presentations across its three programsARIKAYCE, brensocatib, and treprostinil palmitil inhalation powder TPIPat the virtual American Thoracic Society ATS 2021 International Conference. 